SBI / SNBL
Together with SBI / SNBL we drive innovation in Enterprise & AI
SBI Investment: SBI Investment is a leading venture capital firm in Japan, specializing in early to late-stage investments across various industries, including technology, healthcare, and fintech. As a core subsidiary of SBI Holdings, it leverages extensive industry expertise and a global network to support high-growth startups. The firm actively fosters innovation through strategic investments and partnerships, aiming to drive economic and technological advancements. With a strong track record of successful portfolio companies, SBI Investment plays a key role in shaping the future of emerging industries. Its commitment to sustainability and cutting-edge technologies ensures long-term value creation for investors and entrepreneurs alike. SNBL: Shin Nippon Biomedical Laboratories, Ltd. (SNBL), founded in 1957, is Japan's first contract research organization (CRO). The company specializes in pre-clinical testing services for the pharmaceutical industry, including drug analysis, clinical trials, and translational research. SNBL has developed a proprietary nasal drug delivery technology, the μco™ System, which enhances drug absorption through muco-adhesive properties and is applicable to a wide range of drugs.The company's mission is to support drug discovery and improve medical technology, aiming to free humanity from suffering.
FUELING YOUR POTENTIAL
At Plug and Play, we're more than just venture capitalists; we're your partners in growth. We recognize that every startup has a unique journey and we’re here to fuel yours. Our investment criteria are tailored to identify the visionaries, the innovators, and the hard workers. Your startup could be our next success story.
